# Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections

> **NCT03189043** · PHASE2 · UNKNOWN · sponsor: **Aionx, Inc.** · enrollment: 10000 (estimated)

## Conditions studied

- Healthcare Associated Infection

## Interventions

- **DEVICE:** Antimicrobial Surface

## Key facts

- **NCT ID:** NCT03189043
- **Lead sponsor:** Aionx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2017-10-01
- **Final completion:** 2017-10-01
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03189043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03189043, "Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03189043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*